Trial
NCT00660036
Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
University of Pittsburgh
Collaborators
—
Condition
Acute Myeloid Leukemia
Intervention
Gemtuzumab ozogamicin
Why stopped
due to new safety information
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-01-15